Pineapple Express Cannabis (PNXP) Change in Receivables (2024)
Pineapple Express Cannabis' (PNXP) quarterly Change in Receivables came in at $4332.0 in Q4 2024, down 45.22% quarter-over-quarter from $7908.0 in Q3 2024.
Pineapple Express Cannabis (PNXP) Change in Receivables (2024) Analysis & Trends
Pineapple Express Cannabis has disclosed Change in Receivables across 1 years of filings, most recently posting $4332.0 for Q4 2024.
- Change in Receivables for Q4 2024 came in at $4332.0, changed N/A year-over-year; the trailing twelve-month figure through Jul 2025 was $4332.0 (changed N/A YoY), and the FY2025 annual result was $14204.0, changed N/A from the prior year.
- Change in Receivables came in at $4332.0 for Q4 2024 at Pineapple Express Cannabis, down from $7908.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $7908.0 in Q3 2024 to a low of $1964.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 4,332.00 |
| Oct 31, 2024 | 4,332.00 |
| Jul 31, 2024 | 7,908.00 |
| Jul 31, 2024 | 7,908.00 |
| Apr 30, 2024 | 1,964.00 |
| Apr 30, 2024 | 1,964.00 |